Prooxidant-antioxidant balance, hsTnI and hsCRP: Mortality prediction in haemodialysis patients, two-year follow-up

16Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Oxidative stress and inflammation are highly intertwined pathophysiological processes. We analyzed the markers of these processes and high-sensitive troponin I (hsTnI) for mortality prediction in patients on haemodialysis. This study enrolled a total of 62 patients on regular haemodialysis. The patients were monitored for two years, and the observed outcomes were all-cause and cardiovascular mortality. Blood samples were taken before one dialysis session for analysis of the baseline concentrations of prooxidant-antioxidant balance (PAB), total antioxidant status (TAS), total oxidative status (TOS), hsTnI, hsCRP and resistin. The overall all-cause mortality was 37.1% and CVD mortality 16.1%. By univariate and multivariate logistic regression, our findings suggest that good predictors of all-cause mortality include hsCRP and PAB (p

Cite

CITATION STYLE

APA

Antunovic, T., Stefanovic, A., Barhanovic, N. G., Miljkovic, M., Radunovic, D., Ivanisevic, J., … Stojanov, M. (2017). Prooxidant-antioxidant balance, hsTnI and hsCRP: Mortality prediction in haemodialysis patients, two-year follow-up. Renal Failure, 39(1), 491–499. https://doi.org/10.1080/0886022X.2017.1323645

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free